Is There a Role for Locoregional Therapies for Non-colorectal Gastrointestinal Malignancies?

Surg Oncol Clin N Am. 2021 Jan;30(1):125-142. doi: 10.1016/j.soc.2020.08.004. Epub 2020 Oct 28.

Abstract

The liver is the most common site of metastases from solid gastrointestinal tract tumors. Over the past few decades, the role of locoregional therapies, resection and thermal ablation, for neuroendocrine and colorectal liver metastases has been widely studied. However, for liver metastases originating from other gastrointestinal organs, the role of locoregional treatment remains unclear. This review summarizes and discusses the available evidence regarding benefits, risks, and indications for locoregional therapies for non-colorectal and non-neuroendocrine gastrointestinal liver metastases, highlighting the importance of multidisciplinary approach and patient selection.

Keywords: Gastrointestinal cancer; Hepatectomy; Liver; Metastases; Treatment.

Publication types

  • Review

MeSH terms

  • Colorectal Neoplasms* / therapy
  • Gastrointestinal Neoplasms* / therapy
  • Hepatectomy
  • Humans
  • Liver Neoplasms* / surgery
  • Patient Selection